# Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates

> **NCT00037752** · NA · COMPLETED · sponsor: **University of Tennessee** · enrollment: 436 (actual)

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases
- Obesity

## Interventions

- **DRUG:** Sibutramine
- **BEHAVIORAL:** Behavioral Smoking Cessation Program

## Key facts

- **NCT ID:** NCT00037752
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2014-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00037752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00037752, "Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00037752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*